BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 31587598)

  • 1. Is imiquimod a promising drug to treat oral mucosa diseases? A scoping review and new perspectives.
    de Mello Palma V; Frank LA; Balinha DM; Rados PV; Pohlmann AR; Guterres SS; Visioli F
    Br J Clin Pharmacol; 2024 Feb; 90(2):427-439. PubMed ID: 37817570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin Penetration Enhancement Strategies Used in the Development of Melanoma Topical Treatments.
    Tambunlertchai S; Geary SM; Salem AK
    AAPS J; 2021 Jan; 23(1):19. PubMed ID: 33404992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial Peptide Designing and Optimization Employing Large-Scale Flexibility Analysis of Protein-Peptide Fragments.
    Kumar N; Sood D; Tomar R; Chandra R
    ACS Omega; 2019 Dec; 4(25):21370-21380. PubMed ID: 31867532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma.
    Bhatta AK; Wang P; Keyal U; Zhao Z; Ji J; Zhu L; Wang X; Zhang G
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():273-280. PubMed ID: 30030167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-assembled mPEG-hexPLA polymeric nanocarriers for the targeted cutaneous delivery of imiquimod.
    Lapteva M; Mignot M; Mondon K; Möller M; Gurny R; Kalia YN
    Eur J Pharm Biopharm; 2019 Sep; 142():553-562. PubMed ID: 30641138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microemulsions based on TPGS and isostearic acid for imiquimod formulation and skin delivery.
    Pescina S; Garrastazu G; Del Favero E; Rondelli V; Cantù L; Padula C; Santi P; Nicoli S
    Eur J Pharm Sci; 2018 Dec; 125():223-231. PubMed ID: 30316975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imiquimod inhibits melanoma development by promoting pDC cytotoxic functions and impeding tumor vascularization.
    Aspord C; Tramcourt L; Leloup C; Molens JP; Leccia MT; Charles J; Plumas J
    J Invest Dermatol; 2014 Oct; 134(10):2551-2561. PubMed ID: 24751730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imiquimod-oleic acid prodrug-loaded cream reduced drug crystallinity and induced indistinguishable cytotoxicity and apoptosis in mice melanoma tumour.
    Sharma A; Sharma D; Baldi A; Jyoti K; Chandra R; Madan J
    J Microencapsul; 2019 Dec; 36(8):759-774. PubMed ID: 31587598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical treatment of melanoma skin metastases with imiquimod: a review.
    Sisti A; Sisti G; Oranges CM
    Dermatol Online J; 2015 Feb; 21(2):. PubMed ID: 25756475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediators of Inflammation in Topical Therapy of Skin Cancers.
    Voiculescu VM; Lisievici CV; Lupu M; Vajaitu C; Draghici CC; Popa AV; Solomon I; Sebe TI; Constantin MM; Caruntu C
    Mediators Inflamm; 2019; 2019():8369690. PubMed ID: 30766448
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.